[1] FENG RM,ZONG YN,CAO SM,et al.Current cancer situation in China:good or bad news from the 2018 Global Cancer Statistics[J].Cancer Commun(Lond),2019,39(1):22.
[2] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[3] ZHOU JC,ZHENG RS,ZHANG SW,et al.Colorectal cancer burden and trends:comparison between China and major burden countries in the world[J].Chin J Cancer Res,2021,33(1):1-10.
[4] GINI A,JANSEN EEL,ZIELONKE N,et al.Impact of colorectal cancer screening on cancer-specific mortality in Europe:a systematic review[J].Eur J Cancer,2020,127:224-235.
[5] SONG MY,CHAN AT,SUN J.Influence of the gut microbiome,diet,and environment on risk of colorectal cancer[J].Gastroenterology,2020,158 (2):322-340.
[6] XU B,WU Q,LA R,et al.Is systemic inflammation a missing link between cardiometabolic index with mortality?Evidence from a large population-based study[J].Cardiovasc Diabetol,2024,23(1):212.
[7] COUSSENS LM,WERB Z.Inflammation and cancer[J].Nature,2002,420 (6917):860-867.
[8] HAYAMA T,HASHIGUCHI Y,OKADA Y,et al.Significance of the 7th postoperative day neutrophil-to-lymphocyte ratio in colorectal cancer[J].Int J Colorectal Dis,2020,35(1):119-124.
[9] YING HQ,DENG QW,HE BS,et al.The prognostic value of preoperative NLR,d-NLR,PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients[J].Med Oncol,2014,31(12):305.
[10] ROSSI S,BASSO M,STRIPPOLI A,et al.Are markers of systemic inflammation good prognostic indicators in colorectal cancer[J].Clin Colorectal Cancer,2017,16(4):264-274.
[11] HE WB,WEI MT,YANG XY,et al.Do inflammatory markers predict prognosis in patients with synchronous colorectal cancer[J].Medicine(Baltimore),2017,96(17):e6607.
[12] KOZAK MM,VON EYBEN R,PAI JS,et al.The prognostic significance of pretreatment hematologic parameters in patients undergoing resection for colorectal cancer[J].Am J Clin Oncol,2017,40(4):405-412.
[13] SCHROOR MM,JORIS PJ,PLAT J,et al.Effects of intermittent energy restriction compared with those of continuous energy restriction on body composition and cardiometabolic risk markers-a systematic review and meta-analysis of randomized controlled trials in adults[J].Adv Nutr,2024,15(1):100130.
[14] SONG Y,LIU M,YANG FG,et al.Dietary fibre and the risk of colorectal cancer:a case- control study[J].Asian Pac J Cancer Prev,2015,16(9):3747-3752.
[15] LI MS,ZHANG JX,QIN MB,et al.Expression and clinical significance of Tricellulin in colorectal cancer and its relationship with angiogenesis[J].Journal of Colorectal & Anal Surgery,2022,28(2):148.
[16] WAKABAYASHI I,DAIMON T.The cardiometabolic index as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus[J].Clin Chim Acta,2015,438:274-278.
[17]CAI XT,HU JL,WEN W,et al.Associations of the cardiometabolic index with the risk of cardiovascular disease in patients with hypertension and obstructive sleep apnea:Results of a longitudinal cohort study[J].Oxid Med Cell Longev,2022,2022:4914791.
[18] ZOU JW,XIONG HL,ZHANG HM,et al.Association between the cardiometabolic index and non-alcoholic fatty liver disease:insights from a general population[J].BMC Gastroenterol,2022,22(1):20.
[19]RAMIN AD,NAMI MK,ALI H,et al.Waist to height ratio as a simple tool for predicting mortality:a systematic review and meta-analysis[J].Int J Obes(Lond),2023,47(12):1286-1301.
[20] BENEVIDES L,DA FONSECA DM,DONATE PB,et al.IL-17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment[J].Cancer Res,2015,75:3788-3799.
[21] LI ZY,PANG YL,GARA SK,et al.Gr-1+CD11b+ cells are responsible for tumor promoting effect of TGF-β in breast cancer progression[J].Int J Cancer,2012,131:2584-2595.
[22] SILVA RNF,DALLARMI LB,ARAUJO AKC,et al.Immunohistochemical analysis of neutrophils,interleukin-17,matrix metalloproteinase-9,and neoformed vessels in oral squamous cell carcinoma[J].J Oral Pathol Med,2018,47:856-863.
[23] LI J,WANG JY,CHEN RF,et al.The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer[J].Oncotarget,2017,8:15621-15631.
[24] TEMPLETON AJ,MCNAMARA MG,ERUGA B,et al.Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors:a systematic review and meta-analysis[J].J Natl Cancer Inst,2014,106(6):124.
[25] 张羿,朱正秋,薛静.外周血中性粒细胞与淋巴细胞比值预测晚期非小细胞肺癌免疫治疗疗效的价值[J].现代肿瘤医学,2022,30(01):54-57.
ZHANG Yi,ZHU Zhengqiu,XUE Jing.The value of neutrophil-to-lymphocyte ratio(NLR) in predicting the efficacy of advanced non-small cell lung cancer treated with immunotherapy,2022,30(01):54-57.
[26] 崔浩,吴瑶瑶,章龙珍.术前NLR、PLR与三阴性乳腺癌患者预后的相关性分析[J].现代肿瘤医学,2019,27(12):2087-2091.
CUI Hao,WU Yaoyao,ZHANG Longzhen.Correlation between preoperative NLR,PLR and prognosis of three negative breast cancer patients.Modern Oncology,2019,27(12):2087-2091.